Hesitation about potential change to bowel cancer testing
09 December, 2022New research suggests those at risk of bowel cancer would need convincing of potential changes to surveillance techniques and timelines.
Australia 'behind' on cancer liquid biopsy technology
05 December, 2022Researchers at UNSW Sydney are developing safer, less invasive approaches to biopsy tumours.
Australians unite to walk for melanoma awareness
25 November, 2022Australians affected by skin cancer are uniting for Jay's Mission Melanoma walk — over 300 km from Canberra to Sydney.
Non-hormonal oral therapy for breast cancer patients
15 November, 2022QUE Oncology announces the results of its trial of a non-hormonal oral therapy for the treatment of vasomotor symptoms have been published in The Lancet.
New cancer clinical trial platform launched in Melbourne
02 November, 2022A new clinical trial platform, the Brain-POP (brain perioperative), will enable doctors to precisely see the effect of a new drug therapy on a patient's brain cancer for the first time, by comparing tumour samples before and after treatment.
In Conversation with Cyriac Roeding
04 October, 2022 by Mansi GandhiCyriac Roeding, a Silicon Valley-based entrepreneur and investor, sold his first computer program at the age of 15 in Germany.
Australian-first DIPG trial opens at Children's Hospital Westmead
12 September, 2022CHW is currently one of nine sites worldwide to open the trial, known as PNOC-022, which is testing the effectiveness of promising new drug combinations, including the oral drug ONC201.
Tool helps cancer survivors manage post-treatment uncertainty
15 August, 2022UNSW researchers are using e-health to investigate ways to help cancer survivors access treatment for fear of cancer recurrence.
Critical oncology trial data remains hidden: study
01 August, 2022Despite a commitment from the pharmaceutical industry to improve data transparency, more than half of the clinical trials that led to the USFDA approving anticancer medicines over the past 10 years are not available for independent scrutiny.
Combination scans improve outcomes for blood cancer patients
29 June, 2022A Peter Mac-led trial has found that combination PET/CT scans are better at investigating the causes of prolonged fever in blood cancer patients than conventional CT scans.
Partnership to advance oesophageal cancer testing
29 June, 2022QIMR Berghofer has signed an agreement with Proteomics allowing the company to develop and commercialise a blood test for early detection of oesophageal cancer.
Trial to test new strategy for aggresive breast cancer to begin soon
22 June, 2022A clinical trial will use a new strategy to target a 'defence switch' on cancer cells that alerts cancer to the threat of chemotherapy.
Increasing awareness of sun safety
06 June, 2022Skin cancers account for the largest number of newly diagnosed cancers in Australia each year, with incidence of skin cancers being one of the highest in the world.
The role of shared decision-making in cancer treatment
25 May, 2022A patient's perspective on their physical well-being can provide a better indication of their response to cancer treatment than clinician-based tools.
Novel MRI tech for aggressive brain tumours gets funding boost
16 May, 2022The University of South Australia and Ferronova are developing a novel technology to precisely image aggressive brain cancers and guide treatment.
